Melanoma of unknown primary site: Presentation, treatment, and prognosis - A single institution study

Cancer

Volumn 79, Issue 9, 1997, Pages 1816-1821

  Anbari, Kevin K ^a   Schuchter, Lynn M ^a   Bucky, Louis P ^a,b   Mick, Rosemarie ^a   Synnestvedt, Marie ^a   Guerry IV, DuPont ^a   Hamilton, Ralph ^a   Halpern, Allan C ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b Division of Plastic Surgery   (United States)

Author keywords

dysplastic nevus; lymph node metastasis; melanoma; unknown primary site

Indexed keywords

CARMUSTINE; CISPLATIN; DACARBAZINE; TAMOXIFEN;

ADULT; AGE; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DYSPLASTIC NEVUS; FAMILY HISTORY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; SUN EXPOSURE; TREATMENT OUTCOME;

EID: 0030909967     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19970501)79:9<1816::aid-cncr26>3.0.co;2-%23     Document Type: Article

References (22)

1. Das Gupta T, Bowden L, Berg JW. Malignant melanoma of unknown primary. Surg Gynecol Obstet 1963; 117:341-5.
2. Baab GH, McBride CM. Malignant melanoma: the patient with an unknown site of primary origin. Arch Surg 1975; 110:896-900.
3. Milton GW, Shaw HM, McCarthy WH. Occult primary malignant melanoma: factors influencing survival. Br J Surg 1977; 64:805-8.
4. Giuliano AE, Moseley HS, Morton DL. Clinical aspects of unknown primary melanoma. Ann Surg 1980; 191:98-104.
5. Chang P, Knapper WH. Metastatic melanoma of unknown primary. Cancer 1982; 49:1106-11.
6. Reintgen DS, McCarty KS, Woodard B, Cox E, Seigler HF. Metastatic malignant melanoma with an unknown primary. Surg Gynecol Obstet 1983; 156:335-40.
7. Panagopoulos E, Murray D. Metastatic malignant melanoma of unknown primary origin: a study of 30 cases. J Surg Oncol 1983;23:8-10.
8. Wong JH, Cagle LA, Morton DL. Surgical treatment of lymph nodes with metastatic melanoma from unknown primary site. Arch Surg 1987; 122:1380-3.
9. Velez A, Walsh D, Karakousis CP. Treatment of unknown primary melanoma. Cancer 1991; 68:2579-81.
10. Giuliano AE, Cochran AJ, Morton DL. Melanoma from unknown primary site and amelanotic melanoma. Semin Oncol 1982; 9:442-7.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
12. Peto R, Peto J. Asymptomatically efficient rank invariant test procedures (with discussion). J R Stat Soc A 1972; 135:185-206.
13. Cox D. Regression models and life tables (with discussion). J R Star Soc B 1972; 34:187-220.
14. Halpern AC, Guerry D, Elder DE, Clark WH, Synnestvedt M, Norman S, et al. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. Arch Dermatol 1991; 127:995-9.
15. Kelly JW, Holly EA, Shpall SN, Ahn DK. The distribution of melanocytic naevi in melanoma patients and control subjects. Australas J Dermatol 1989; 30:1-8.
16. Augustsson A, Stierner U, Rosdahl I, Suurkula M. Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population. Acta Derm Venereol 1991; 71:518-24.
17. Holly EA, Kelly JW, Shpall SN, Chiu SH. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987; 17:459-468.
18. Garbe C, Buttner P, Weib J, et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the central malignant melanoma registry of the German Dermatological Society. J Invest Dermatol 1994; 102:695-9.
19. Nasri S, Namazie A, Dulguerov P, Mickel R. Malignant melanoma of cervical and parotid lymph nodes with an unknown primary site. Laryngoscope 1994; 104:1194-8.
20. Norman J, Cruse CW, Wells KE, Saba HI, Reintgen DS. Metastatic melanoma with an unknown primary. Ann Plast Surg 1992; 28:81-4.
21. Kosaoy CL, Ies LAG, Miller BA, Hankey BF, Harras A, Edwards BK. SEER Cancer Statistics Review, 1973-1992 Tables and Graphs, National Cancer Institute. NIH Pub. No. 96-2789. Bethesda: National Institutes of Health, 1995:303-5.
22. Coit DG, Rogatko A, Brennan MF. Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes: a multivariate analysis. Ann Surg 1991; 214:627-36.